PPAR agonists contribute to prevent obesity in adult life and other associated diseases by decreasing adiposity and increasing the expression of antioxidant and lipolytic genes (Willson et al., 2001; Bassaganya-Riera et al., 2011). This evidence concerns the gene PPARA and obesity disorder.